Ethan R. Goldman
Lawyers
Filters
Cantel Medical $140 million convertible senior notes offering
Davis Polk the initial purchasers in connection with a Rule 144A offering by Cantel Medical Corp. of $140 million principal amount of 3.250% convertible senior notes due 2025. Cantel’s…
First American Financial $450 million senior notes offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by First American Financial Corporation of …
AtriCure $201.2 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a SEC-registered follow-on offering of 4,573,863 shares of common stock…
Ingredion $1 billion senior notes offering
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Ingredion Incorporated of $600 million aggregate principal amount of 2.900%…
Roku $503 million at-the-market offering
Davis Polk advised the sales agents on an approximately $503 million SEC-registered at-the-market offering by Roku, Inc. consisting of up to 4,000,000 shares of its Class A common…
IBM $4 billion notes offering
Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of $1.25 billion aggregate principal amount of its 1.700% due 2027, …
Metro de Santiago $1.5 billion notes offering and cash tender offer
Davis Polk advised the initial purchasers in connection with the offering by Empresa de Transporte de Pasajeros Metro S.A. (Metro de Santiago) of $1.5 billion aggregate principal…
Corporación Nacional del Cobre de Chile $800 million notes offering
Davis Polk advised the initial purchasers in connection with the offering by Corporación Nacional del Cobre de Chile of $800 million aggregate principal amount of its 3.750% notes due 2031…
Fifth Third Bancorp $1.25 billion debt offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering of $500 million aggregate principal amount of 1.625% senior notes due 2023 and $750 million…
Aeglea BioTherapeutics $138 million stock and pre-funded warrants offering
Davis Polk advised the joint book-running managers in connection with a $138 million SEC-registered common stock and pre-funded warrants offering by Aeglea, including the full exercise…